← All stocks

Bioventus Inc.

BVS Net selling
CIK 0001665988 #2414 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$312.35K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$312.35K
3 of 3 sales
Net
−$312.35K
−$312.35K against sales at will

By person

14 insiders · 3 transactions
1.4×

Robert E. Claypoole holds only 1.4 times base salary in stock. $1.19M of shares against $824.11K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert E. Claypoole last reported holding, valued at $8.79, the price Class A Common Stock was last bought or sold at on the open market here, on 11 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
McMurry-Heath Michelle
Director
$236.69K (2)
−$236.69K
77,279
0.114%
$679.02K
+60.3%
NOHRA GUY P
Director
$75.66K (1)
−$75.66K
148,892
0.219%
$1.31M
+48.7%
HAWKINS WILLIAM A
Director
297,640
0.439%
$2.62M
+28.6%
Singleton Mark Leonard
SVP & CFO
177,333
0.261%
$1.56M
+108.9%
D'Adamio Anthony
SVP & General Counsel
153,655
0.226%
$1.35M
+60.8%
STALNECKER SUSAN M
Director
138,239
0.204%
$1.21M
+74.0%
Claypoole Robert E
President and CEO
135,944
0.200%
$1.19M
NEELS GUIDO J
Director
117,523
0.173%
$1.03M
+100.0%
SUTTER MARTIN P
Director
117,523
0.173%
$1.03M
+100.0%
Bartholdson John A.
Director
111,902
0.165%
$983.24K
+145.7%
Ladone Mary Kay
Director
111,263
0.164%
$977.62K
+112.0%
Beyer Pat
Director
108,718
0.160%
$955.26K
+117.7%
CHURCH KATRINA J
SVP & Chief Compliance Officer
64,164
0.095%
$563.78K
+55.7%
Cowdy Philip G.
Director
43,982
0.065%
$386.45K
+275.9%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 689,654
History held since 16 Feb 2021